aluates Reports

$ 0.0

Automative

Global RNA Interference (RNAi)-Based Therapeutics Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-37U16206

Global RNA Interference RNAi Based Therapeutics Market Research Report 2023

BUY CHAPTERS

Global RNA Interference (RNAi)-Based Therapeutics Market Research Report 2025

Code: QYRE-Auto-37U16206

Report

May 2025

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Alnylam

Novartis

Sylentis

Arrowhead

Silence Therapeutics

Dicerna

RNA Interference (RNAi)-Based Therapeutics Market Size

The global market for RNA Interference (RNAi)-Based Therapeutics was valued at US$ 2047 million in the year 2024 and is projected to reach a revised size of US$ 10960 million by 2031, growing at a CAGR of 27.5% during the forecast period.

RNA Interference (RNAi)-Based Therapeutics Market

The Small Interfering RNA (siRNA) Drugs Market is driven by the transformative potential of siRNA-based therapies in silencing disease-associated genes, making them a promising approach for treating a wide range of diseases, including genetic disorders, viral infections, and various cancers. siRNA drugs work by selectively degrading or inhibiting the expression of specific genes, offering a highly targeted and personalized treatment option. As the understanding of genomics and RNA interference mechanisms advances, and the need for precision medicine grows, the demand for siRNA drugs continues to rise. Innovations in siRNA design, delivery systems, and gene-editing technologies further contribute to market expansion. However, a significant challenge for this market is the need to overcome delivery barriers, ensure the stability and safety of siRNA therapeutics, and navigate regulatory complexities. Addressing off-target effects, optimizing pharmacokinetics, and managing the high cost of siRNA drug development are ongoing challenges. Additionally, the market faces competition from traditional therapeutic approaches and the need for continuous research and development to unlock the full therapeutic potential of siRNA drugs. Striking a balance between providing safe, effective, and accessible siRNA therapies while addressing scientific and regulatory challenges is essential for the continued growth of the Small Interfering RNA (siRNA) Drugs Market.

This report aims to provide a comprehensive presentation of the global market for RNA Interference (RNAi)-Based Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Interference (RNAi)-Based Therapeutics.

The RNA Interference (RNAi)-Based Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNA Interference (RNAi)-Based Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the RNA Interference (RNAi)-Based Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of RNA Interference (RNAi)-Based Therapeutics Market Report

Report Metric	Details
Report Name	RNA Interference (RNAi)-Based Therapeutics Market
Accounted market size in year	US$ 2047 million
Forecasted market size in 2031	US$ 10960 million
CAGR	27.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	siRNA miRNA shRNA
Segment by Application	AHP hATTR Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alnylam, Novartis, Sylentis, Arrowhead, Silence Therapeutics, Dicerna
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Interference (RNAi)-Based Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is RNA Interference (RNAi)-Based Therapeutics Market growing?

Ans: The RNA Interference (RNAi)-Based Therapeutics Market witnessing a CAGR of 27.5% during the forecast period 2025-2031.

What is the RNA Interference (RNAi)-Based Therapeutics Market size in 2031?

Ans: The RNA Interference (RNAi)-Based Therapeutics Market size in 2031 will be US$ 10960 million.

Who are the main players in the RNA Interference (RNAi)-Based Therapeutics Market report?

Ans: The main players in the RNA Interference (RNAi)-Based Therapeutics Market are Alnylam, Novartis, Sylentis, Arrowhead, Silence Therapeutics, Dicerna

What are the Application segmentation covered in the RNA Interference (RNAi)-Based Therapeutics Market report?

Ans: The Applications covered in the RNA Interference (RNAi)-Based Therapeutics Market report are AHP, hATTR, Other

What are the Type segmentation covered in the RNA Interference (RNAi)-Based Therapeutics Market report?

Ans: The Types covered in the RNA Interference (RNAi)-Based Therapeutics Market report are siRNA, miRNA, shRNA

Recommended Reports

RNAi Therapeutics

Gene Therapy

Nucleic Acid Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global RNA Interference (RNAi)-Based Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 siRNA

1.2.3 miRNA

1.2.4 shRNA

1.3 Market by Application

1.3.1 Global RNA Interference (RNAi)-Based Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 AHP

1.3.3 hATTR

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global RNA Interference (RNAi)-Based Therapeutics Market Perspective (2020-2031)

2.2 Global RNA Interference (RNAi)-Based Therapeutics Growth Trends by Region

2.2.1 Global RNA Interference (RNAi)-Based Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 RNA Interference (RNAi)-Based Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 RNA Interference (RNAi)-Based Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 RNA Interference (RNAi)-Based Therapeutics Market Dynamics

2.3.1 RNA Interference (RNAi)-Based Therapeutics Industry Trends

2.3.2 RNA Interference (RNAi)-Based Therapeutics Market Drivers

2.3.3 RNA Interference (RNAi)-Based Therapeutics Market Challenges

2.3.4 RNA Interference (RNAi)-Based Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top RNA Interference (RNAi)-Based Therapeutics Players by Revenue

3.1.1 Global Top RNA Interference (RNAi)-Based Therapeutics Players by Revenue (2020-2025)

3.1.2 Global RNA Interference (RNAi)-Based Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global RNA Interference (RNAi)-Based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by RNA Interference (RNAi)-Based Therapeutics Revenue

3.4 Global RNA Interference (RNAi)-Based Therapeutics Market Concentration Ratio

3.4.1 Global RNA Interference (RNAi)-Based Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by RNA Interference (RNAi)-Based Therapeutics Revenue in 2024

3.5 Global Key Players of RNA Interference (RNAi)-Based Therapeutics Head office and Area Served

3.6 Global Key Players of RNA Interference (RNAi)-Based Therapeutics, Product and Application

3.7 Global Key Players of RNA Interference (RNAi)-Based Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 RNA Interference (RNAi)-Based Therapeutics Breakdown Data by Type

4.1 Global RNA Interference (RNAi)-Based Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global RNA Interference (RNAi)-Based Therapeutics Forecasted Market Size by Type (2026-2031)

5 RNA Interference (RNAi)-Based Therapeutics Breakdown Data by Application

5.1 Global RNA Interference (RNAi)-Based Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global RNA Interference (RNAi)-Based Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America RNA Interference (RNAi)-Based Therapeutics Market Size (2020-2031)

6.2 North America RNA Interference (RNAi)-Based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2020-2025)

6.4 North America RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe RNA Interference (RNAi)-Based Therapeutics Market Size (2020-2031)

7.2 Europe RNA Interference (RNAi)-Based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2020-2025)

7.4 Europe RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific RNA Interference (RNAi)-Based Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific RNA Interference (RNAi)-Based Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific RNA Interference (RNAi)-Based Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific RNA Interference (RNAi)-Based Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America RNA Interference (RNAi)-Based Therapeutics Market Size (2020-2031)

9.2 Latin America RNA Interference (RNAi)-Based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2020-2025)

9.4 Latin America RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa RNA Interference (RNAi)-Based Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa RNA Interference (RNAi)-Based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Alnylam

11.1.1 Alnylam Company Details

11.1.2 Alnylam Business Overview

11.1.3 Alnylam RNA Interference (RNAi)-Based Therapeutics Introduction

11.1.4 Alnylam Revenue in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025)

11.1.5 Alnylam Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis RNA Interference (RNAi)-Based Therapeutics Introduction

11.2.4 Novartis Revenue in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Sylentis

11.3.1 Sylentis Company Details

11.3.2 Sylentis Business Overview

11.3.3 Sylentis RNA Interference (RNAi)-Based Therapeutics Introduction

11.3.4 Sylentis Revenue in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025)

11.3.5 Sylentis Recent Development

11.4 Arrowhead

11.4.1 Arrowhead Company Details

11.4.2 Arrowhead Business Overview

11.4.3 Arrowhead RNA Interference (RNAi)-Based Therapeutics Introduction

11.4.4 Arrowhead Revenue in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025)

11.4.5 Arrowhead Recent Development

11.5 Silence Therapeutics

11.5.1 Silence Therapeutics Company Details

11.5.2 Silence Therapeutics Business Overview

11.5.3 Silence Therapeutics RNA Interference (RNAi)-Based Therapeutics Introduction

11.5.4 Silence Therapeutics Revenue in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025)

11.5.5 Silence Therapeutics Recent Development

11.6 Dicerna

11.6.1 Dicerna Company Details

11.6.2 Dicerna Business Overview

11.6.3 Dicerna RNA Interference (RNAi)-Based Therapeutics Introduction

11.6.4 Dicerna Revenue in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025)

11.6.5 Dicerna Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Alnylam

Novartis

Sylentis

Arrowhead

Silence Therapeutics

Dicerna

List of Tables

Table 1. Global RNA Interference (RNAi)-Based Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of siRNA

Table 3. Key Players of miRNA

Table 4. Key Players of shRNA

Table 5. Global RNA Interference (RNAi)-Based Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global RNA Interference (RNAi)-Based Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global RNA Interference (RNAi)-Based Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global RNA Interference (RNAi)-Based Therapeutics Market Share by Region (2020-2025)

Table 9. Global RNA Interference (RNAi)-Based Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global RNA Interference (RNAi)-Based Therapeutics Market Share by Region (2026-2031)

Table 11. RNA Interference (RNAi)-Based Therapeutics Market Trends

Table 12. RNA Interference (RNAi)-Based Therapeutics Market Drivers

Table 13. RNA Interference (RNAi)-Based Therapeutics Market Challenges

Table 14. RNA Interference (RNAi)-Based Therapeutics Market Restraints

Table 15. Global RNA Interference (RNAi)-Based Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global RNA Interference (RNAi)-Based Therapeutics Market Share by Players (2020-2025)

Table 17. Global Top RNA Interference (RNAi)-Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Interference (RNAi)-Based Therapeutics as of 2024)

Table 18. Ranking of Global Top RNA Interference (RNAi)-Based Therapeutics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by RNA Interference (RNAi)-Based Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of RNA Interference (RNAi)-Based Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of RNA Interference (RNAi)-Based Therapeutics, Product and Application

Table 22. Global Key Players of RNA Interference (RNAi)-Based Therapeutics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global RNA Interference (RNAi)-Based Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global RNA Interference (RNAi)-Based Therapeutics Revenue Market Share by Type (2020-2025)

Table 26. Global RNA Interference (RNAi)-Based Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global RNA Interference (RNAi)-Based Therapeutics Revenue Market Share by Type (2026-2031)

Table 28. Global RNA Interference (RNAi)-Based Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global RNA Interference (RNAi)-Based Therapeutics Revenue Market Share by Application (2020-2025)

Table 30. Global RNA Interference (RNAi)-Based Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global RNA Interference (RNAi)-Based Therapeutics Revenue Market Share by Application (2026-2031)

Table 32. North America RNA Interference (RNAi)-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe RNA Interference (RNAi)-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific RNA Interference (RNAi)-Based Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific RNA Interference (RNAi)-Based Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific RNA Interference (RNAi)-Based Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America RNA Interference (RNAi)-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa RNA Interference (RNAi)-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa RNA Interference (RNAi)-Based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Alnylam Company Details

Table 48. Alnylam Business Overview

Table 49. Alnylam RNA Interference (RNAi)-Based Therapeutics Product

Table 50. Alnylam Revenue in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 51. Alnylam Recent Development

Table 52. Novartis Company Details

Table 53. Novartis Business Overview

Table 54. Novartis RNA Interference (RNAi)-Based Therapeutics Product

Table 55. Novartis Revenue in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 56. Novartis Recent Development

Table 57. Sylentis Company Details

Table 58. Sylentis Business Overview

Table 59. Sylentis RNA Interference (RNAi)-Based Therapeutics Product

Table 60. Sylentis Revenue in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 61. Sylentis Recent Development

Table 62. Arrowhead Company Details

Table 63. Arrowhead Business Overview

Table 64. Arrowhead RNA Interference (RNAi)-Based Therapeutics Product

Table 65. Arrowhead Revenue in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 66. Arrowhead Recent Development

Table 67. Silence Therapeutics Company Details

Table 68. Silence Therapeutics Business Overview

Table 69. Silence Therapeutics RNA Interference (RNAi)-Based Therapeutics Product

Table 70. Silence Therapeutics Revenue in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 71. Silence Therapeutics Recent Development

Table 72. Dicerna Company Details

Table 73. Dicerna Business Overview

Table 74. Dicerna RNA Interference (RNAi)-Based Therapeutics Product

Table 75. Dicerna Revenue in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025) & (US$ Million)

Table 76. Dicerna Recent Development

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

Table 80. Authors List of This Report

List of Figures

Figure 1. RNA Interference (RNAi)-Based Therapeutics Picture

Figure 2. Global RNA Interference (RNAi)-Based Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global RNA Interference (RNAi)-Based Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. siRNA Features

Figure 5. miRNA Features

Figure 6. shRNA Features

Figure 7. Global RNA Interference (RNAi)-Based Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global RNA Interference (RNAi)-Based Therapeutics Market Share by Application: 2024 VS 2031

Figure 9. AHP Case Studies

Figure 10. hATTR Case Studies

Figure 11. Other Case Studies

Figure 12. RNA Interference (RNAi)-Based Therapeutics Report Years Considered

Figure 13. Global RNA Interference (RNAi)-Based Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global RNA Interference (RNAi)-Based Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global RNA Interference (RNAi)-Based Therapeutics Market Share by Region: 2024 VS 2031

Figure 16. Global RNA Interference (RNAi)-Based Therapeutics Market Share by Players in 2024

Figure 17. Global Top RNA Interference (RNAi)-Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Interference (RNAi)-Based Therapeutics as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by RNA Interference (RNAi)-Based Therapeutics Revenue in 2024

Figure 19. North America RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America RNA Interference (RNAi)-Based Therapeutics Market Share by Country (2020-2031)

Figure 21. United States RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe RNA Interference (RNAi)-Based Therapeutics Market Share by Country (2020-2031)

Figure 25. Germany RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific RNA Interference (RNAi)-Based Therapeutics Market Share by Region (2020-2031)

Figure 33. China RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America RNA Interference (RNAi)-Based Therapeutics Market Share by Country (2020-2031)

Figure 41. Mexico RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa RNA Interference (RNAi)-Based Therapeutics Market Share by Country (2020-2031)

Figure 45. Turkey RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE RNA Interference (RNAi)-Based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Alnylam Revenue Growth Rate in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025)

Figure 49. Novartis Revenue Growth Rate in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025)

Figure 50. Sylentis Revenue Growth Rate in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025)

Figure 51. Arrowhead Revenue Growth Rate in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025)

Figure 52. Silence Therapeutics Revenue Growth Rate in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025)

Figure 53. Dicerna Revenue Growth Rate in RNA Interference (RNAi)-Based Therapeutics Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Small Interfering RNA siRNA Drugs Market Research Report 2024

Global Small Interfering RNA siRNA Therapeutics Market Insights Forecast to 2030

Global RNAi Therapeutics Market Research Report 2024

Global Vector Based RNAi Market Research Report 2024

Global siRNA Drugs Market Research Report 2024

Global siRNA Drug Market Research Report 2024

Antisense and RNAi Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global RNA Interference RNAi Drug Delivery Market Research Report 2025

Global RNA Therapeutics Market Research Report 2024

Global Antisense and RNA Interference Therapeutics Market Research Report 2024

RNAi Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nucleic Acid Drugs Market Research Report 2025

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RNAi Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Nucleic Acid Drug Market Research Report 2025

Global RNA based Therapeutics Drug Market Research Report 2024

Global Oligonucleotide Therapeutics Market Research Report 2024

RNA Based Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide based Therapy Medicinal Product Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions